Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had revenue of $67.77M in the quarter ending September 30, 2024, with 24.32% growth. This brings the company's revenue in the last twelve months to $220.36M, up 38.72% year-over-year. In the year 2023, Aurinia Pharmaceuticals had annual revenue of $175.51M with 30.95% growth.

• Revenue (ttm): $220.36M
• Revenue Growth: +38.72%
• P/S Ratio: 5.16
• Revenue / Employee: $734,537
• Employees: 300
• Market Cap: 1.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	175.51M	41.48M	30.95%
Dec 31, 2022	134.03M	88.43M	193.89%
Dec 31, 2021	45.61M	-4.51M	-9.00%
Dec 31, 2020	50.12M	49.80M	15,660.38%
Dec 31, 2019	318.00K	-145.00K	-31.32%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.